Antimicrobial Susceptibility Testing of Burkholderia Cepacia
Abstract Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. Aim of the present study was to analyze the impact of biofield treatment on multidrug resistant B. cepacia. Clinical sample of B. cepacia was divided into two groups i.e. control and biofield treated. The analysis was done after 10 days of treatment and compared with control group. Control and treated group were analyzed for susceptibility pattern, MIC value, biochemical studies and biotype number using MicroScan Walk-Away® system. Citation Information Mahendra Kumar Trivedi.
• Biofield Treatment
• Natural therapy
• Mahendra Kumar Trivedi Publications | Biofield
• Trivedi Science
• Effect Of Biofield On Burkholderia cepacia